Peripartum cardiomyopathy
Peripartum cardiomyopathy (PPCM) is a rare, dilated heart disease of unknown origin and potentially fatal, for which various hypotheses have been postulated to explain its genesis, among which are viral myocarditis, immune response and own hemodynamic stress of pregnancy, among others. It usually be...
| Main Authors: | , , , |
|---|---|
| Format: | Online |
| Language: | spa |
| Published: |
Subcomité editorial y de evaluación de obras de la Facultad de Ciencias de la Salud Editora Revista Dra. Bibiana Matilde Bernal Gómez
2020
|
| Subjects: | |
| Online Access: | https://revistas.uptc.edu.co/index.php/salud_sociedad/article/view/11838 |
| _version_ | 1801706821392531456 |
|---|---|
| author | Cárdenas Casallas, Laura Daniela Rueda Monsalbe, Amanecer Castañeda Martínez, Diego Andrés Pinilla Romero, Erika Eliana |
| author_facet | Cárdenas Casallas, Laura Daniela Rueda Monsalbe, Amanecer Castañeda Martínez, Diego Andrés Pinilla Romero, Erika Eliana |
| author_sort | Cárdenas Casallas, Laura Daniela |
| collection | OJS |
| description | Peripartum cardiomyopathy (PPCM) is a rare, dilated heart disease of unknown origin and potentially fatal, for which various hypotheses have been postulated to explain its genesis, among which are viral myocarditis, immune response and own hemodynamic stress of pregnancy, among others. It usually begins with clinical manifestations of heart failure, which appear during the last month of pregnancy or the five months postpartum. As for the diagnosis, it is considered difficult to carry out, due to the number of diseases that have the same clinical characteristics and considering that other entities can overcome it, for this reason it is considered a diagnosis of exclusion, that is why , its diagnostic approach implies to achieve a complete history, whose findings are supported by paraclinical tests that allow to rule out other possible etiologies that may explain the affectation to the health of the pregnant woman. Another aspect of particular importance encompasses therapeutic considerations, for which it is necessary to keep in mind regimens that acomplish the best quality of life for both pregnant and postpartum women as well as for the product of pregnancy. The objective of this review article is to present updated information on this pathology, including aspects such as its epidemiology, risk factors, clinical manifestations, diagnostic approach, and pharmacological and life-support therapeutic measures.
|
| format | Online |
| id | oai:oai.revistas.uptc.edu.co:article-11838 |
| institution | Revista Salud & Sociedad |
| language | spa |
| publishDate | 2020 |
| publisher | Subcomité editorial y de evaluación de obras de la Facultad de Ciencias de la Salud Editora Revista Dra. Bibiana Matilde Bernal Gómez |
| record_format | ojs |
| spelling | oai:oai.revistas.uptc.edu.co:article-118382023-11-28T19:35:14Z Peripartum cardiomyopathy Miocardiopatía periparto Cardiomiopatia periparto Cárdenas Casallas, Laura Daniela Rueda Monsalbe, Amanecer Castañeda Martínez, Diego Andrés Pinilla Romero, Erika Eliana peripatetic myocardiopatia pregnancy heart failure miocardiopatia peripato embarazo insuficiencia cardíaca miocardiopatia peripatética gravidez insuficiência cardíaca Peripartum cardiomyopathy (PPCM) is a rare, dilated heart disease of unknown origin and potentially fatal, for which various hypotheses have been postulated to explain its genesis, among which are viral myocarditis, immune response and own hemodynamic stress of pregnancy, among others. It usually begins with clinical manifestations of heart failure, which appear during the last month of pregnancy or the five months postpartum. As for the diagnosis, it is considered difficult to carry out, due to the number of diseases that have the same clinical characteristics and considering that other entities can overcome it, for this reason it is considered a diagnosis of exclusion, that is why , its diagnostic approach implies to achieve a complete history, whose findings are supported by paraclinical tests that allow to rule out other possible etiologies that may explain the affectation to the health of the pregnant woman. Another aspect of particular importance encompasses therapeutic considerations, for which it is necessary to keep in mind regimens that acomplish the best quality of life for both pregnant and postpartum women as well as for the product of pregnancy. The objective of this review article is to present updated information on this pathology, including aspects such as its epidemiology, risk factors, clinical manifestations, diagnostic approach, and pharmacological and life-support therapeutic measures. La miocardiopatía periparto (PPCM) es una cardiopatía dilatada, rara, de origen desconocido y potencialmente mortal, para la cual se han postulado diversas hipótesis para explicar su génesis, dentro de los cuales estan la miocarditis viral, la respuesta inmune y el estrés hemodinámico propios del embarazo, entre otros. Suele debutar con manifestaciones clínicas de insuficiencia cardíaca, las cuales aparecen durante el último mes del embarazo o los cinco meses posparto. En cuanto al diagnóstico se considera difícil de llevar a cabo, a raíz de la cantidad de enfermedades que tienen las mismas características clínicas y considerando que otras entidades se pueden sobreponer a esta, por dicha razón se considera un diagnóstico de exclusión, razón por la cual, su abordaje diagnóstico implica la realización de una historia completa, cuyos hallazgos se apoyen en examenes paraclínicos que permitan descartar otras posibles etiologías que puedan explicar la afectación a la salud de la gestante. Otro aspecto de particular importancia engloba a las consideraciones terapéuticas, para lo cual es necesario tener en mente esquemas que tengan como objetivo lograr la mejor calidad de vida tanto para la mujer embarazada como el posparto como para el producto de la gestación. El objetivo del presente artículo de revisión es presentar información actualizada sobre esta patología, incluyendo aspectos como su epidemiología, factores de riesgo, manifestaciones clínicas, abordaje diagnóstico y medidas terapéuticas farmacológicas y de soporte vital. A cardiomiopatia periparto (CMPP) é uma doença cardíaca dilatada rara, de origem desconhecida e potencialmente fatal, para a qual várias hipóteses foram postuladas para explicar sua gênese, incluindo miocardite viral, resposta imune e estresse hemodinâmico da gravidez, entre outras. Geralmente começa com manifestações clínicas de insuficiência cardíaca, que aparecem durante o último mês de gravidez ou cinco meses após o parto. Quanto ao diagnóstico, é considerado de difícil execução, devido ao número de doenças que apresentam as mesmas características clínicas e considerando que outras entidades podem se sobrepor a ele, por isso é considerado um diagnóstico de exclusão, razão pela qual sua abordagem diagnóstica envolve a realização de uma anamnese completa, cujos achados são apoiados por exames paraclínicos que permitem descartar outras possíveis etiologias que possam explicar o agravo à saúde da gestante. Outro aspecto de particular importância envolve considerações terapêuticas, para as quais é necessário ter em mente esquemas que visem à melhor qualidade de vida tanto para a gestante quanto para o período pós-parto, bem como para o produto da gestação. O objetivo deste artigo de revisão é apresentar informações atualizadas sobre essa patologia, incluindo aspectos como sua epidemiologia, fatores de risco, manifestações clínicas, abordagem diagnóstica e medidas terapêuticas farmacológicas e de suporte à vida. Subcomité editorial y de evaluación de obras de la Facultad de Ciencias de la Salud Editora Revista Dra. Bibiana Matilde Bernal Gómez 2020-10-22 info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion application/pdf https://revistas.uptc.edu.co/index.php/salud_sociedad/article/view/11838 Salud & Sociedad Uptc; Vol. 5 Núm. 2 (2020): Salud y Sociedad Uptc volumen 5 número 2 2020; 1-36 2744-953X 2389-8038 spa https://revistas.uptc.edu.co/index.php/salud_sociedad/article/view/11838/13630 Derechos de autor 2020 Salud & Sociedad https://creativecommons.org/licenses/by-nc-nd/4.0/ |
| spellingShingle | peripatetic myocardiopatia pregnancy heart failure miocardiopatia peripato embarazo insuficiencia cardíaca miocardiopatia peripatética gravidez insuficiência cardíaca Cárdenas Casallas, Laura Daniela Rueda Monsalbe, Amanecer Castañeda Martínez, Diego Andrés Pinilla Romero, Erika Eliana Peripartum cardiomyopathy |
| title | Peripartum cardiomyopathy |
| title_alt | Miocardiopatía periparto Cardiomiopatia periparto |
| title_full | Peripartum cardiomyopathy |
| title_fullStr | Peripartum cardiomyopathy |
| title_full_unstemmed | Peripartum cardiomyopathy |
| title_short | Peripartum cardiomyopathy |
| title_sort | peripartum cardiomyopathy |
| topic | peripatetic myocardiopatia pregnancy heart failure miocardiopatia peripato embarazo insuficiencia cardíaca miocardiopatia peripatética gravidez insuficiência cardíaca |
| topic_facet | peripatetic myocardiopatia pregnancy heart failure miocardiopatia peripato embarazo insuficiencia cardíaca miocardiopatia peripatética gravidez insuficiência cardíaca |
| url | https://revistas.uptc.edu.co/index.php/salud_sociedad/article/view/11838 |
| work_keys_str_mv | AT cardenascasallaslauradaniela peripartumcardiomyopathy AT ruedamonsalbeamanecer peripartumcardiomyopathy AT castanedamartinezdiegoandres peripartumcardiomyopathy AT pinillaromeroerikaeliana peripartumcardiomyopathy AT cardenascasallaslauradaniela miocardiopatiaperiparto AT ruedamonsalbeamanecer miocardiopatiaperiparto AT castanedamartinezdiegoandres miocardiopatiaperiparto AT pinillaromeroerikaeliana miocardiopatiaperiparto AT cardenascasallaslauradaniela cardiomiopatiaperiparto AT ruedamonsalbeamanecer cardiomiopatiaperiparto AT castanedamartinezdiegoandres cardiomiopatiaperiparto AT pinillaromeroerikaeliana cardiomiopatiaperiparto |
